Radiotherapy toxicity

D De Ruysscher, G Niedermann, NG Burnet… - Nature Reviews …, 2019 - nature.com
Radiotherapy is used in> 50% of patients with cancer, both for curative and palliative
purposes. Radiotherapy uses ionizing radiation to target and kill tumour tissue, but normal …

Long-term endocrine and metabolic consequences of cancer treatment: a systematic review

J Gebauer, C Higham, T Langer, C Denzer… - Endocrine …, 2019 - academic.oup.com
The number of patients surviving≥ 5 years after initial cancer diagnosis has significantly
increased during the last decades due to considerable improvements in the treatment of …

[HTML][HTML] The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions

U Feldt-Rasmussen, G Effraimidis, M Klose - Molecular and Cellular …, 2021 - Elsevier
The hypothalamus-pituitary-thyroid axis is one of several hormone regulatory systems from
the hypothalamus to the pituitary and ultimately to the peripheral target organs. The …

Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus

M Lambrecht, DBP Eekers, C Alapetite… - Radiotherapy and …, 2018 - Elsevier
Purpose For unbiased comparison of different radiation modalities and techniques,
consensus on delineation of radiation sensitive organs at risk (OARs) and on their dose …

Long‐term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma

TA Lawrie, D Gillespie, T Dowswell… - Cochrane Database …, 2019 - cochranelibrary.com
Background Gliomas are brain tumours arising from glial cells with an annual incidence of 4
to 11 people per 100,000. In this review we focus on gliomas with low aggressive potential …

Supportive care: an indispensable component of modern oncology

R Berman, A Davies, T Cooksley, R Gralla, L Carter… - Clinical Oncology, 2020 - Elsevier
The advent of new cancer therapies, alongside expected growth and ageing of the
population, better survival rates and associated costs of care, is uncovering a need to more …

Central hypothyroidism—a neglected thyroid disorder

P Beck-Peccoz, G Rodari, C Giavoli… - Nature reviews …, 2017 - nature.com
Central hypothyroidism is a rare and heterogeneous disorder that is characterized by a
defect in thyroid hormone secretion in an otherwise normal thyroid gland due to insufficient …

Adrenal insufficiency: physiology, clinical presentation and diagnostic challenges

J Martin-Grace, R Dineen, M Sherlock, CJ Thompson - Clinica chimica acta, 2020 - Elsevier
Adrenal insufficiency (AI) is a serious condition, which can arise from pathology affecting the
adrenal gland itself (primary adrenal insufficiency, PAI), hypothalamic or pituitary pathology …

What we have to know about corticosteroids use during Sars-Cov-2 infection

F Ferraù, F Ceccato, S Cannavò, C Scaroni - Journal of endocrinological …, 2021 - Springer
Abstract Purpose Glucocorticoids (GCs), alone or associated to other drugs, were widely
used in the management of patients affected by severe acute respiratory syndrome caused …

Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma

S Tabrizi, BY Yeap, JC Sherman, LB Nachtigall… - Radiotherapy and …, 2019 - Elsevier
Background Patients with low-grade gliomas (LGG) can survive years with their illness.
Proton radiotherapy (PRT) can reduce off-target dose and decrease the risk of treatment …